SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
-20.72%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$451M
AUM Growth
+$451M
(-0.45%)
Cap. Flow
+$86.2M
Cap. Flow
% of AUM
19.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
4
Reduced
1
Closed
1
Top Buys
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$29.9M |
| 2 |
Puma Biotechnology
PBYI
|
$27.3M |
| 3 |
AGN
Allergan plc
AGN
|
$27.1M |
| 4 |
MDCO
Medicines Co
MDCO
|
$16.4M |
| 5 |
Innoviva
INVA
|
$9.01M |
Top Sells
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$20.5M |
| 2 |
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
|
$3.03M |
Sector Composition
| 1 | Healthcare | 88.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$19.4B
| $139M | 30.8% | 461,858 | – | – |
|
|
2
Innoviva
INVA
$1.29B
| $88.1M | 19.53% | 5,051,100 +516,100 | +11% | +$9.01M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $73M | 16.19% | 546,500 +202,500 | +59% | +$27.1M |
|
|
4
Ironwood Pharmaceuticals
IRWD
$214M
| $64.8M | 14.35% | 6,252,300 +2,885,200 | +86% | +$29.9M |
|
|
MDCO
5
DELISTED
Medicines Co
MDCO
| $53.2M | 11.8% | 2,781,000 +859,000 | +45% | +$16.4M |
|
|
6
Puma Biotechnology
PBYI
$254M
| $27.3M | 6.06% | +1,343,000 | New | +$27.3M |
|
|
ICPT
7
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.44M | 1.21% | 54,000 -203,500 | -79% | -$20.5M |
|
|
SHPG
8
DELISTED
Shire pic
SHPG
| $174K | 0.04% | 1,000 | – | – |
|
9
AbbVie
ABBV
$372B
| $92K | 0.02% | 1,000 | – | – |
|
|
MRTX
10
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $42K | 0.01% | +1,000 | New | +$42K |
|
|
NVLN
11
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| – | – | -1,025,000 | Closed | -$3.03M |
|